#ShortenTheJourney
February 18, 2026 | Education, Real World Outcomes, rare disease
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven by a simple but systemic hurdle: many healthcare professionals (HCPs) rarely encounter specific rare conditions in daily practice, and symptoms are often variable and non-specific, leading to missed signs and misdiagnoses. However, new research by Medscape presented at the World Orphan Drug Congress Europe 2025 suggests a powerful solution lies in precision targeted medical education.
The Power of Targeted Learning
A series of analyses conducted by Medscape Education Global evaluated how online Continuing Medical Education (CME) influences real-world clinical behavior. By tracking insurance claims and National Provider Identifier (NPI) data, researchers compared clinicians who participated in rare disease education against similar cohorts who did not. The results across various specialties—neurology, gastroenterology, and endocrinology—were consistent and striking.
- Genetic testing in pediatric neurology: Specialists who participated in education were 69% more likely to order critical genetic tests, such as multigene panels, specific genetic tests, and whole exome sequencing compared with those who didn’t participate1
- Rare endocrinology: Education was associated with a significant 157% increase in claims for rare conditions like Cushing syndrome and X-linked hypophosphatemia2
- Rare liver disorders: A significant 120% increase in coding for conditions such as Alagille syndrome and hepatic porphyria from gastroenterologists/hepatologists2
- Rare neurological conditions: Participation in CME was associated with a significant 78.5% increase in claims for 11 complex conditions, including ALS and Rett syndrome2
Why It Matters
The significance of these findings rests in the shift from theoretical knowledge and competence to active clinical application. By providing online, accessible education on a free, membership-based platform, rare disease education gives doctors the knowledge, competence, and confidence to order the right diagnostic tests, and apply the correct diagnostic codes earlier.
These studies suggest that online education is a powerful clinical intervention and a positive lever to improve patient outcomes. By equipping healthcare providers with the tools to recognize “the zebras among the horses,” we can shorten the diagnostic journey, ensuring patients receive life-altering treatments years earlier than they otherwise would.
References:
- Rohani-Montez SC et al. Are Pediatric Neurologists Who Participate in Rare Disease Education More Likely to Order Genetic Tests for Rare Diseases? Presented at World Orphan Drug Congress Europe 2025
- Rohani-Montez SC et al. Continuing Medical Education is Significantly Associated With Increased Rare Neurological, Endocrine and Liver Disease Diagnoses in Real World Practice. Presented at World Orphan Drug Congress Europe 2025
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Getting Past the Old-Fashioned View of Patient Advocacy
Patient advocacy organizations today are data-driven, doing amazing work — and have the hard evidence to support their impact on patient care. The challenge is getting past the perception of…
Mile High Impact at AAN 2024
The Medscape team will be joining our neurology colleagues in Denver, CO for this year’s AAN Annual Meeting. Impact will take center stage at this year’s event as Medscape presents…
Everything Was Peachy at ACC 2024 in Atlanta, GA
The annual ACC meeting has officially wrapped up in Atlanta, bringing a successful conference to a close for another year. During the conference, members of the Medscape team hosted a…
A Woman Should Not Be Treated As a Small Man
What should the future of women’s healthcare look like? Two renowned physicians say it involves a multidisciplinary, holistic approach, where a group of different specialists work together to provide a…
Sharing Four Times the Impact at ACC 2024
ACC is kicking off next week in Atlanta, GA, and Medscape is heading south to join our cardiology colleagues. The Medscape team will be hosting booth #3431 on the exhibit…
Transforming San Diego for AAD 2024
The 2024 meeting of the American Academy of Dermatology has wrapped up, and Medscape has returned from a series of successful days at their booth, symposia, and offsite event. To…
The Power Dynamics of Women and Cancer
Women, Power, and Cancer: a Lancet commission, studied the interaction of women and cancer through a social justice and equity lens. What does ‘power’ mean when it comes to cancer…
Evaluating the Forces Shaping Women’s Healthcare
Gaps in women’s healthcare go beyond access and cost. Do clinicians have the tools they need to understand women’s health?
Shortening the Journey at the Unusual Suspects Meeting
Medscape will be continuing their mission to shorten the diagnostic journey for patients with a rare disease at this year’s Unusual Suspects event on February 21.The Unusual Suspects is an…
Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series
What are some of the biggest gaps that women face in healthcare today? “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine….